Peripheral and tumor-associated NK cells in STAT3-targeted tumor-bearing mice, exhibit higher expression of the NK activation markers NKG2D, CD69, Fas ligand (FasL), granzyme B, perforin, and IFNγ, resulting in reduced tumor growth and enhanced survival (80, 81). This evidence concerns the gene KLRK1 and neoplasm.